Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations | Zendy

Jesse D. Sammon | Zendy; Firas Abdollah | Zendy; Toni K. Choueiri | Zendy; Philip W. Kantoff | Zendy; Paul L. Nguyen | Zendy; Mani Me | Zendy; QuocDien Trinh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations

Author(s) -

Jesse D. Sammon,

Firas Abdollah,

Toni K. Choueiri,

Philip W. Kantoff,

Paul L. Nguyen,

Mani Me,

QuocDien Trinh

Publication year - 2015

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2015.7273

Subject(s) - medicine , task force , prostate specific antigen , observational study , prostate cancer screening , task (project management) , family medicine , prostate , public administration , cancer , political science , management , economics

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations Prostate-specific antigen (PSA) screening is a widely debated practice in the United States, given that PSA screening can lead to the diagnosis of nonlethal prostate cancer and the harms associated with treatment of such disease.1 In this context, the 2008 US Preventive Services Task Force (USPSTF) panel recommended against PSA screening in men older than 75 years. This recommendation, however, has been ineffective at reducing the observed prevalence of PSA screening among older men.2 More recently, the USPSTF issued a grade D recommendation against PSA screening for all men, regardless of age.3

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research